AROCELL AB (PUBL)AROCELL AB (PUBL)AROCELL AB (PUBL)

AROCELL AB (PUBL)

No trades
See on Supercharts

AROC fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

AroCell AB is a in vitro diagnostics company, which engages in the monitoring of hematological malignancies, breast cancer, and other solid tumors. Its products include AroCell TK 210 ELISA, which was designed for simple, robust, and scalable measurement of Thymidine Kinase 1 in blood samples. The company was founded by Karl Axel Staffan Eriksson, Arne Ferstad, Qi Min He, Per Nils Jesper Matsson, Sven Skog, and Bernhard Tribukait in 2003 and is headquartered in Stockholm, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
AROC has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company